Smart bet, only option, or both?

2026

Open publication workspace · Sign in to read the full PDF.

AI-generated summary

This report details how Artificial Intelligence is revolutionizing biopharma R&D, offering solutions to persistent challenges and driving future innovation.

* Explores the imperative for AI adoption in biopharma R&D, highlighting its potential to transform drug discovery and development.
* Analyzes the current state of AI implementation across the R&D value chain, identifying key use cases and benefits.
* Outlines critical recommendations for biopharma organizations to accelerate and scale AI adoption, addressing data readiness and operational challenges.

Tags: AI, Biopharma, R&D, Drug Discovery, Innovation

Check the original publication for accuracy and context.